Posted by Michael Wonder on 11 Aug 2020
Petitioner demands insurance benefit for breast cancer drug Kadcyla
11 August 2020 - A woman has requested that the government grant reimbursement for using Kadcyla of Roche in treating people with early breast cancer at high risk of recurrence, on Cheong Wa Dae's petition website.
On July 31, the petitioner posted the demand titled, "The government should not discriminate patients who have cancer that is difficult to treat in accessing new effective drugs."
The woman, who introduced herself as a daughter of a patient suffering from HER2 positive breast cancer patient, said that she had to give up treatment for her mother due to the expensive treatment cost of Kadcyla. The petition has won more than 770 signatures as of Tuesday.
